Earnings and Revenue Beat
For the second quarter, Pfizer posted adjusted earnings of 60 cents per share, significantly outperforming the expected 46 cents. Revenue reached $13.28 billion, surpassing the projected $12.96 billion and marking a 2% increase year-over-year. Net income for the quarter stood at $41 million, or 1 cent per share, compared to $2.33 billion, or 41 cents per share, in the same period last year.
Revised Full-Year Outlook
In light of these strong results, Pfizer has upgraded its full-year forecast. The company now anticipates adjusted earnings between $2.45 and $2.65 per share, up from the previous projection of $2.15 to $2.35 per share. Revenue expectations have also been raised to a range of $59.5 billion to $62.5 billion, an increase from the earlier forecast of $58.5 billion…
Read More
